Clinical Trial Update: Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a soluble epoxide hydrolase (s-EH) inhibitor in patients with hypertension and impaired glucose tolerance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Impaired Glucose Tolerance

Drugs mentioned

• Soluble epoxide hydrolase inhibitor

Snippet

Sponsor: Arete Therapeutics | Conditions: Hypertension, Impaired Glucose Tolerance | Phase 2 | Status: COMPLETED